Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

GBTG Q2 2025 Earnings Call Transcript

TheMotleyFool 
0 0 05.08.25
GBTG Q2 2025 Earnings Call TranscriptPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
 

Image source: The Motley Fool.

Tuesday, Aug. 5, 2025 at 1:00 p.m. ET

Chief Executive Officer — Paul Abbott

Continue reading


Source Fool.com

Abbott Laboratories Stock

€91.70
0.350%
Abbott Laboratories gained 0.350% compared to yesterday.
The stock is an absolute favorite of our community with 69 Buy predictions and no Sell predictions.
With a target price of 114 € there is a positive potential of 24.32% for Abbott Laboratories compared to the current price of 91.7 €.
Show more
Like: 0
GBTG
Share

Comments

Not a member yet? Sign up for free!